Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
9 Questions on Primary CV Disease Prevention
The 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease could change your clinical practice. Try these 9 questions to find out how.
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality globally, an outcome related to less than optimal implementation of prevention strategies and epidemics of uncontrolled risk factors in the adult population.
The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease was commissioned both to consolidate existing guidance and incorporate new understanding of the importance of risk factor mitigation in decreasing individual ASCVD risk.
How much do you know about the updates? Take our 9-question quiz below to find out.
Related Videos
Related Content
